Measurement of oxidized lipoprotein (a) in patients with acute coronary syndromes and stable coronary artery disease by 2 ELISAs: using different capture antibody against oxidized lipoprotein (a) or oxidized LDL.

[1]  Chunni Zhang,et al.  Elevated concentrations of oxidized lipoprotein(a) are associated with the presence and severity of acute coronary syndromes. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[2]  Chunni Zhang,et al.  Plasma oxidized lipoprotein(a) and its immune complexes are present in newborns and children. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[3]  H. Cai,et al.  Native, oxidized lipoprotein(a) and lipoprotein(a) immune complex in patients with active and inactive rheumatoid arthritis: plasma concentrations and relationship to inflammation. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[4]  Li Fu,et al.  Development of new enzyme-linked immunosorbent assay for oxidized lipoprotein(a) by using purified human oxidized lipoprotein(a) autoantibodies as capture antibody. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[5]  F. Kronenberg,et al.  Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study. , 2006, Journal of the American College of Cardiology.

[6]  E. Brilakis,et al.  Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. , 2005, The New England journal of medicine.

[7]  Chunni Zhang,et al.  Lipoprotein (a) and its immune complexes in dyslipidemic subjects. , 2004, Clinical biochemistry.

[8]  B. Strauss,et al.  Percutaneous Coronary Intervention Results in Acute Increases in Oxidized Phospholipids and Lipoprotein(a): Short-Term and Long-Term Immunologic Responses to Oxidized Low-Density Lipoprotein , 2004, Circulation.

[9]  G. Getz,et al.  Lysine-Phosphatidylcholine Adducts in Kringle V Impart Unique Immunological and Potential Pro-inflammatory Properties to Human Apolipoprotein(a)* , 2003, Journal of Biological Chemistry.

[10]  Joseph Juliano,et al.  Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes. , 2003, Journal of the American College of Cardiology.

[11]  T. Ogihara,et al.  Development of Antibody Against Epitope of Lipoprotein(a) Modified by Oxidation: Evaluation of New Enzyme-Linked Immunosorbent Assay for Oxidized Lipoprotein(a) , 2000, Circulation.

[12]  F. Romero,et al.  Autoantibodies against malondialdehyde-modified lipoprotein(a) in antiphospholipid syndrome. , 1999, Arthritis and rheumatism.

[13]  E. Podrez,et al.  Measurement of oxidation in plasma Lp(a) in CAPD patients using a novel ELISA. , 1998, Kidney international.

[14]  X. Yao,et al.  Quantitation of plasminogen epitopes of serum lipoprotein(a) by sandwich enzyme linked immunosorbent assay. , 1997, Clinica chimica acta; international journal of clinical chemistry.

[15]  D. Sgoutas,et al.  Oxidized lipoprotein (a) induces cell adhesion molecule Mac-1 (CD 11b) and enhances adhesion of the monocytic cell line U937 to cultured endothelial cells. , 1996, Atherosclerosis.

[16]  D. Altman,et al.  Comparing methods of measurement: why plotting difference against standard method is misleading , 1995, The Lancet.

[17]  C. Hamm,et al.  Rapid angiographic progression of coronary artery disease in patients with elevated lipoprotein(a) , 1995, Circulation.

[18]  H. Hoff,et al.  Partial characterization of lipoproteins containing apo[a] in human atherosclerotic lesions. , 1993, Journal of lipid research.

[19]  A. Scanu,et al.  Malondialdehyde modification of lipoprotein(a) produces avid uptake by human monocyte-macrophages. , 1992, The Journal of biological chemistry.

[20]  R. Lawn,et al.  Lipoprotein(a) and atherosclerosis. , 1991, Annals of internal medicine.

[21]  G. Rice,et al.  Interaction of recombinant apolipoprotein(a) and lipoprotein(a) with macrophages. , 1991, The Journal of clinical investigation.

[22]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[23]  Chunni Zhang,et al.  Detection of IgG-bound lipoprotein(a) immune complexes in patients with coronary heart disease. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[24]  J. Davignon,et al.  Oxidative modification of Lp(a) causes changes in the structure and biological properties of apo(a). , 1994, Chemistry and physics of lipids.

[25]  A. Gotto,et al.  CORONARY ARTERY DISEASE Association of levels of lipoprotein Lp ( a ) , plasma lipids , and other lipoproteins with coronary artery disease documented by angiography , 2022 .